Related Experiment Videos
[Surgery of retroperitoneal sarcomas]
S Bonvalot1, D Vanel, A Le Cesne
1Département de Chirurgie, Comité Sarcome, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif cedex, France. bonvalot@igr.fr
Summary
Retroperitoneal sarcomas are rare tumors. Complete surgical resection is the primary treatment, though local control rates are around 50%, and adjuvant therapies are still under investigation.
Area of Science:
- Oncology
- Radiology
- Surgical Pathology
Context:
- Retroperitoneal sarcomas represent a significant portion of soft tissue sarcomas and retroperitoneal tumors.
- Accurate diagnosis and staging are crucial for effective management.
- Surgical resection remains the cornerstone of treatment.
Purpose:
- To outline the diagnostic and treatment strategies for retroperitoneal sarcomas.
- To emphasize the importance of complete surgical resection.
- To discuss the current understanding of adjuvant therapy's role.
Summary:
- Helical CT and MRI are key imaging modalities for assessing tumor extent, location, necrosis, and metastasis.
- CT-guided core needle biopsy is the preferred method for preoperative tissue sampling.
- Complete surgical resection, potentially involving adjacent organs, is the mainstay of treatment, with a 5-year local control rate of approximately 50%.
Impact:
- Highlights the critical role of advanced imaging and biopsy in surgical planning.
- Underscores the challenges in achieving long-term local control for these tumors.
- Advises against routine adjuvant therapy outside of clinical trials, emphasizing current evidence limitations.